Medtronic Plc. announced the launch of a new hybrid closed-loop system for North America & Europe artificial pancreas systems market
The increasing incidence of type 1 diabetes is significantly fueling the growth of the North America & Europe artificial pancreas systems market. For instance, according to the Centers for Disease Control and Prevention (CDC), in the U.S., around 40,000 people are diagnosed with Type 1 diabetes, annually, and by 2050, 5 million people are expected to be diagnosed with the disease, in the country. Moreover, Germany had the highest prevalence of diabetes in Europe among their adult population with 15.3 percent living with diabetes in 2019, Portugal followed with the second-highest share at 14.2 percent. Furthermore, the growing adoption of high-end systems in diabetes management is further projected to foster the growth of the North America & Europe artificial pancreas systems market. North America region is expected to hold a dominant position in North America & Europe artificial pancreas systems market and this is attributed to the presence of a well-established he...